RecruitingNCT06533813

Clinical Epidemiology in Contemporary Patients With Myelofibrosis.

Clinical Epidemiology in Contemporary Patients With Myelofibrosis (ERNEST-3): A European LeukemiaNet (ELN) Observational Study

Sponsor

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Enrollment

617 participants

Start Date

Oct 14, 2024

Study Type

OBSERVATIONAL

Conditions

Myelofibrosis

Summary

Multicenter retrospective and prospective European observational study. At each site, all consecutive patients with a 2016- or 2022 World Health Organization (WHO) confirmed diagnosis of myelofibrosis (MF) established from 01/01/2018 to 31/12/2027 will be enrolled into the study. Yearly follow-up updates will be scheduled until the end of data collection on 31/12/2028 or until the last available patient visit, whichever comes first. At least 1 year of follow-up will be ensured from the last patient enrolled.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with myelofibrosis. The study is currently recruiting participants at 27 locations. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(27)

Hematology Center after Prof.R.H. Yeolyan

Yerevan, Armenia

University Hospital Halle Department of Hematology/Oncology

Halle, Germany

University Medicine Hannover

Hanover, Germany

University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden UKRUB, University of Bochum

Minden, Germany

A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia

Alessandria, Italy

ASST Papa Giovanni XXIII, SC Ematologia

Bergamo, Italy

Policlinico S. Orsola - Malpighi, Unità di Ematologia

Bologna, Italy

Azienda Ospedaliero - Universitaria "Policlinico Vittorio Emanuele" - PO Gaspare Rodolico, Dipartimento di ematologia con Trapianto di midollo Osseo

Catania, Italy

AOU Careggi di Firenze, Divisione di Ematologia

Florence, Italy

ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia

Milan, Italy

Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Ematologia

Milan, Italy

Ospedale San Raffaele, Unità Operativa di Ematologia e Trapianto Midollo Osseo

Milan, Italy

Fondazione IRCCS San Gerardo dei Tintori

Monza, Italy

Azienda Ospedaliera Universitaria Federico II, Divisione di Ematologia

Naples, Italy

Azienda Ospedaliero Universitaria Maggiore della Carità, SCDU Ematologia

Novara, Italy

Fondazione IRCCS Policlinico San Matteo, Divisione di Ematologia

Pavia, Italy

Fondazione Policlinico Universitario A. Gemelli - Università Cattolica del Sacro Cuore, UCSC Ematologia

Roma, Italy

Policlinico Umberto I, Dipartimento Ematologia, Oncologia e Dermatologia

Roma, Italy

A.O.U. Città della Salute e della Scienza di Torino - Ospedale Molinette- S.C. Ematologia U

Torino, Italy

Ospedale Cardinale G. Panico

Tricase, Italy

Azienda Ospedaliera Universitaria Integrata - Ospedale Borgo Roma, Unità di Ematologia

Verona, Italy

Azienda ULSS 8 Berica - Ospedale San Bortolo, Divisione di Ematologia

Vicenza, Italy

Department of Hematology, University Hospital, Jagiellonian University Medical College

Krakow, Poland

Department and Clinic of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University

Wroclaw, Poland

Department of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute

Bucharest, Romania

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) - Hospital Clinic

Barcelona, Spain

Hematology and Hemotherapy Department, 12 de Octubre University Hospital

Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06533813

Related Trials

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

NCT063454951 location

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT0532019828 locations

Haplo-HSCT for Myelofibrosis

NCT066743821 location

A Telehealth Advance Care Planning Intervention

NCT058758051 location

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

NCT07623161207 locations